Sign Out
Pregnancy: Teratogenic Effects: Pregnancy Category C: There are no or limited amount of data from the use of this product in pregnant women. However, no effects on pregnancy are anticipated since the systemic exposure to moxifloxacin from topical ocular application is negligible.
Since there are no adequate and well-controlled studies in pregnant women, the product should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Lactation: It is unknown whether moxifloxacin/metabolites are excreted in human milk. Animal studies have shown excretion of low levels in breast milk after oral administration of moxifloxacin. However, at therapeutic doses of moxifloxacin no effects on the suckling child are anticipated.
